Jose M. Castro-De
Gasteiz / Vitoria, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus.
Journal: Platelets
Published: May 14, 2024
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
Journal: Journal of clinical medicine
Published: September 04, 2023
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima).
Journal: EJHaem
Published: June 16, 2023
Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
Journal: Infectious diseases and therapy
Published: November 02, 2022
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75-year-olds newly diagnosed with multiple myeloma.
Journal: European journal of haematology
Published: July 20, 2021
Diffuse bone marrow metastases of small cell carcinoma with associated erythrophagocytosis mimicking acute leukaemia.
Journal: Hematology, transfusion and cell therapy
Published: March 21, 2021
Primary plasma cell leukaemia presenting with flower-shaped nuclei.
Journal: British journal of haematology
Published: February 22, 2021
Treatment burden in multiple myeloma according to comorbidity in real life.
Journal: Annals of hematology
Published: December 28, 2020
Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study.
Journal: BMC health services research
Published: July 17, 2020
Faggot cells in therapy-related acute myeloid leukemia with inv(16).
Journal: Clinical case reports
Published: June 25, 2020
Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group.
Journal: Advances in hematology
Published: April 30, 2019
Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors
Journal: Medicina clinica
Published: January 07, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026